Ignite Creation Date:
2024-05-05 @ 6:33 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00504790
Status:
COMPLETED
Last Update Posted:
2018-07-12
First Post:
2007-07-18
Brief Title:
Phase I Study to Assess the Safety Pharmacokinetics Pharmacodynamics of GSK923295 in Subjects w Refractory Cancer
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline